35:08duration 35 minutes 8 seconds
Martine Roussel - From Erb, Mac and Myb to CDK…
Martine Roussel - From Erb, Mac and Myb to CDK inhibitors and medulloblastoma mechanisms and new targeted therapies
Tony Hunter 50th Symposium
53:10duration 53 minutes 10 seconds
Recent Chalk Talks - Intorductions Montage V.2
18:13duration 18 minutes 13 seconds
Talmo Pereira Towards a foundation model for HPI
01:12:57duration 1 hour 12 minutes
Dannie Engle - Pancreas Cancer
UCSD Cancer Course 2024
18:31duration 18 minutes 31 seconds
Takeya Masubuchi - Evolutionary fingerprint in…
Takeya Masubuchi - Evolutionary fingerprint in rodent PO1 confers weakened activity and enhanced tumor immunity compared to human PO1
LJIC 2024
01:13:31duration 1 hour 13 minutes
Dannielle Engle - Chalk Talk
01:16:34duration 1 hour 16 minutes
Dan Hollern - Chalk Talk
05:54duration 5 minutes 54 seconds
Nathan Shock - Pilot Grant Call information…
Nathan Shock - Pilot Grant Call information session
14:57duration 14 minutes 57 seconds
Nathan Shock - Intro
33:38duration 33 minutes 38 seconds
The Power of Persistence - Session 2: The…
The Power of Persistence - Session 2: The Lustgarten Foundation Career Development Award Lecture in honor of Ruth Bader Ginsburg
Ashley Kiemen International Women's…
01:33:16duration 1 hour 33 minutes
Cancer Center EAB February - Session 3
01:14:54duration 1 hour 14 minutes
Danni Engle - Modeling Pancreatic Cancer
33:52duration 33 minutes 52 seconds
J. Silvio Gutkind - Targeting Cancer Signaling…
J. Silvio Gutkind - Targeting Cancer Signaling Networks in the Era of Precision Medicine: Novel Multimodal Immunotherapies
34:16duration 34 minutes 16 seconds
Tal Einav - Forecasting the Antibody Response…
Tal Einav - Forecasting the Antibody Response against Influenza
29:09duration 29 minutes 9 seconds
Juliana Idoyaga - Emerging Dendritic Cell…
Juliana Idoyaga - Emerging Dendritic Cell Heterogeneity: the in-betweens
14:33duration 14 minutes 33 seconds
Anna Zagorska - How can we stop dysfunctional…
Anna Zagorska - How can we stop dysfunctional signaling in chronic fibrotic diseases – RTKs and beyond